Essex Property Trust, Inc. (ESS) Stock Price Today
Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Life360 director Morin Brit sells 15,582 shares for $1 million
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
Airbus leads aerospace market with strong orders despite production challenges
Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...
Allstate invests in quantum computing to enhance insurance risk pricing ahead of tech arrival.
Insurance company Allstate is proactively investing in quantum computing, expanding its team to explore how the technology can improve risk-based pricing for policies. CEO Tom Wilson acknowledges uncertainty about when quantum computing will fully de...
Vanguard Growth ETF switches benchmark index with no immediate impact on investors.
On July 29, 2026, Vanguard changed the benchmark index for its Growth ETF (VUG) from the CRSP US Large Cap Growth Index to the Morningstar US Large Cap Growth Index following Morningstar's acquisition of CRSP. The fund's investment strategy and holdi...
Solar ETF TAN up 7% YTD but lags S&P; key is pending US tariff decision on imports.
The Invesco Solar ETF (TAN) is up about 7% year to date, underperforming the S&P 500's 14% gain, despite solar energy's growing share in new US power capacity. The fund's largest holding, First Solar, is down 14% YTD even after strong earnings and sa...
NexGen starts major construction on Rook I uranium project after final federal approval
NexGen Energy has received final federal approval and begun major construction on its Rook I uranium project, positioning itself as a rare Western supplier amid global supply constraints. The project advances faster than peers still facing permitting...
Broadcom stock falls 6% on $370B AI financing concern; AMD rises 4% on strong AI growth outlook.
Broadcom's stock dropped 6% after Bank of America highlighted a potential $370 billion senior debt linked to its AI chip financing vehicle, raising concerns about its off-balance-sheet exposure. Meanwhile, AMD's shares climbed 4% following Baird's bu...
Capricor Therapeutics jumps 75% amid FDA talks on Duchenne Muscular Dystrophy drug update
Capricor Therapeutics' stock surged 75% following news of ongoing FDA negotiations for its drug deramiocel, targeting Duchenne Muscular Dystrophy with cardiomyopathy. The company plans to amend its Biologics License Application (BLA) with extended 24...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.